Company Filing History:
Years Active: 2018-2023
Title: Innovator Profile: Katarina Pindric – Pioneering Glycopeptide Solutions
Introduction: Katarina Pindric, based in Sesvete, Croatia, is a distinguished inventor known for her significant contributions in the field of pharmaceuticals. With a total of six patents to her name, Pindric has made remarkable strides in the development of glycopeptide compositions, specifically focusing on the stability and formulation of antibiotic solutions.
Latest Patents: Katarina Pindric's latest patents revolve around glycopeptide compositions that include solutions comprising glycopeptide antibiotics, such as Vancomycin, combined with amino acids or their derivatives like N-acetyl-Glycine and N-acetyl-D-Alanine. These innovative solutions are designed to remain stable over extended periods under typical storage and usage conditions. Pindric's patents also encompass manufacturing methods for these solutions, their application in pharmaceutical settings, and techniques for enhancing the stability of glycopeptide antibiotics through the use of amino acid derivatives.
Career Highlights: Pindric has been an influential figure at Xellia Pharmaceuticals Aps, where she has contributed to the advancement of pharmaceutical technology. Her work has not only garnered patents but also recognition within the scientific community for addressing critical challenges in antibiotic formulation and stability.
Collaborations: Throughout her career, Katarina Pindric has collaborated with talented individuals, including colleagues Ivona Jasprica and Sabina Keser. These collaborations highlight the team-oriented approach prevalent in the research and development sector, fostering innovation and progress in pharmaceutical sciences.
Conclusion: Katarina Pindric exemplifies a driven inventor who merges scientific expertise with innovative thinking. Her groundbreaking work on glycopeptide compositions is a testament to her dedication to enhancing healthcare through improved pharmaceutical solutions. As she continues to make strides in her field, Pindric’s contributions will undoubtedly influence the future landscape of antibiotic therapies.